Advanced Therapy Medicinal Products in Vitiligo; Current Status, Future Prospect, and Approved Treatments

Vitiligo is an auto-immune disease, causing depigmentation of skin in 0.2-1.8% of global population. Topical corticosteroids and calcineurin inhibitors are the only treatments with firm evidence of optimal effectiveness with considerable side effects. Phototherapies might not induce serious side eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghashghaei, Shahriar, Abbaszadeh, Mahkameh, Karimi, Shahedeh, Ataie-Fashtami, Leila, Bajouri, Amir, Vosough, Massoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royan Institute 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105300/
https://www.ncbi.nlm.nih.gov/pubmed/37038694
http://dx.doi.org/10.22074/CELLJ.2023.557550.1067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105300/
https://www.ncbi.nlm.nih.gov/pubmed/37038694
http://dx.doi.org/10.22074/CELLJ.2023.557550.1067

Ejemplares similares